CIK 0001299130 · Accelerated filer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Sign in to watch- Ticker
- PACB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161590339
- Phone
- 650-521-8000
- Business address
- 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025
- Former names
- PACIFIC BIOSCIENCES OF CALIFORNIA INC, NANOFLUIDICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,087,330
- in 2 filings, $2.1M under 10b5-1 plans
Net −$2,087,330. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-06 | Gibson James R II See Remarks | Option exercise 10b5-1 | +500,000 | $1.18 | $590K | 1,745,663 |
| 2026-10-06 | Gibson James R II See Remarks | Sale 10b5-1 | −661,815 | $3.11 | $2.1M | 1,083,848 |
| 2026-10-06 | Gibson James R II See Remarks | Option exercise · Stock Option (right to buy) 10b5-1 | −500,000 | 1,500,000 | ||
| 2026-08-17 | Van Oene Mark See Remarks | Sale | −26,911 | $1.13 | $30K | 2,705,853 |
| 2026-08-10 | Van Oene Mark See Remarks | Grant or award | +489,130 | 2,732,764 | ||
| 2026-08-10 | Van Oene Mark See Remarks | Grant or award · Stock Option (right to buy) | +1,967,888 | 1,967,888 | ||
| 2026-06-03 | MOHR MARSHALL Director | Grant or award · Stock Option (right to buy) | +223,492 | 223,492 | ||
| 2026-06-03 | Gibson Christopher Director | Grant or award · Stock Option (right to buy) | +74,497 | 74,497 | ||
| 2026-06-03 | Smith Christopher M Director | Grant or award · Stock Option (right to buy) | +223,492 | 223,492 | ||
| 2026-06-03 | Valantine Hannah Director | Grant or award · Stock Option (right to buy) | +223,492 | 223,492 | ||
| 2026-06-03 | LIVINGSTON RANDALL S Director | Grant or award · Stock Option (right to buy) | +223,492 | 223,492 | ||
| 2026-06-03 | Ericson William W. Director | Grant or award · Stock Option (right to buy) | +223,492 | 223,492 | ||
| 2026-06-03 | MILLIGAN JOHN F Director | Grant or award · Stock Option (right to buy) | +223,492 | 223,492 | ||
| 2026-06-03 | ORDONEZ KATHY Director | Grant or award · Stock Option (right to buy) | +223,492 | 223,492 | ||
| 2026-04-08 | Gibson Christopher Director | Grant or award | +57,473 | 111,386 | ||
| 2026-04-08 | Gibson Christopher Director | Grant or award · Stock Option (right to buy) | +77,842 | 77,842 | ||
| 2026-04-01 | Gibson James R II See Remarks | Sale | −88,185 | $1.37 | $121K | 1,245,663 |
| 2026-03-03 | Gibson Christopher Director | Grant or award | +53,913 | 53,913 | ||
| 2026-03-03 | Gibson Christopher Director | Grant or award · Stock Option (right to buy) | +73,087 | 73,087 | ||
| 2026-03-03 | HENRY CHRISTIAN O See Remarks | Sale | −12,497 | $1.51 | $19K | 3,581,813 |
Page 1 of 29 · 561 trades